Best-in-Class PTRS
Achieve superior technical and regulatory success.
Predict human clinical responses to investigational agents as early as the drug discovery stage.
Best-in-class PTRS solutions dramatically increase the success rates of investigational drugs.
REDUCE
Risks
BOOST
Revenues
ACCELERATE
Timelines
IMPROVE
ROI
Cellworks biosimulation methodology and PTRS solutions.
The Cellworks Platform is powered by the Cellworks Computational Biology Model (CBM), a network of 6,000+ human genes, 55,000+ molecular species and 600,000+ molecular interactions.
Address key business challenges with best-in-class PTRS.
Reduce technical and
regulatory risks.
Expand markets for
existing drugs.
Improve clinical trial
success rates.
